The recurrent TCF4 missense variant p.(Arg389Cys) causes a neurodevelopmental disorder overlapping with but not typical for Pitt-Hopkins syndrome.

PTHS Pitt-Hopkins syndrome TCF4 intellectual disability missense variant neurodevelopmental disorder

Journal

Clinical genetics
ISSN: 1399-0004
Titre abrégé: Clin Genet
Pays: Denmark
ID NLM: 0253664

Informations de publication

Date de publication:
12 2022
Historique:
revised: 20 07 2022
received: 28 06 2022
accepted: 25 07 2022
pubmed: 31 7 2022
medline: 4 11 2022
entrez: 30 7 2022
Statut: ppublish

Résumé

TCF4 haploinsufficiency by deletions, truncating variants or loss-of-function missense variants within the DNA-binding and protein interacting bHLH domain causes Pitt-Hopkins syndrome (PTHS). This neurodevelopmental disorder (NDD) is characterized by severe intellectual disability (ID), epilepsy, hyperbreathing and a typical facial gestalt. Only few aberrations of the N-terminus of TCF4 were associated with milder or atypical phenotypes. By personal communication and searching databases we assembled six cases with the novel, recurrent, de novo missense variant c.1165C > T, p.(Arg389Cys) in TCF4. This variant was identified by diagnostic exome or panel sequencing and is located upstream of the bHLH domain. All six individuals presented with moderate to severe ID with language impairment. Microcephaly occurred in two individuals, epilepsy only in one, and no breathing anomalies or myopia were reported. Facial gestalt showed some aspects of PTHS but was rather non-specific in most individuals. Interestingly, the variant is located within the AD2 activation domain next to a highly conserved coactivator-recruitment motif and might alter interaction with coactivator proteins independently from the bHLH domain. Our findings of a recurrent missense variant outside the bHLH domain in six individuals with an ID phenotype overlapping with but not typical for PTHS delineate a novel genotype-phenotype correlation for TCF4-related NDDs.

Identifiants

pubmed: 35908153
doi: 10.1111/cge.14206
pmc: PMC10108566
doi:

Substances chimiques

Transcription Factor 4 0
TCF4 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

517-523

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

© 2022 The Authors. Clinical Genetics published by John Wiley & Sons Ltd.

Références

Am J Hum Genet. 2009 Apr;84(4):524-33
pubmed: 19344873
Nucleic Acids Res. 2014 Jun;42(11):7370-82
pubmed: 24682819
Am J Med Genet A. 2012 Jul;158A(7):1604-11
pubmed: 22678594
Neurogenetics. 2018 Jan;19(1):41-47
pubmed: 29322350
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
J Biol Chem. 2021 Dec;297(6):101381
pubmed: 34748727
Am J Hum Genet. 2007 May;80(5):994-1001
pubmed: 17436255
Hum Mol Genet. 2012 Jul 1;21(13):2873-88
pubmed: 22460224
Nucleic Acids Res. 2019 Sep 19;47(16):8375-8387
pubmed: 31081034
Eur J Med Genet. 2017 Nov;60(11):565-571
pubmed: 28807867
J Med Genet. 2008 Nov;45(11):738-44
pubmed: 18728071
Eur J Med Genet. 2016 Jun;59(6-7):310-4
pubmed: 27132474
Hum Mutat. 2012 Jan;33(1):64-72
pubmed: 22045651
Clin Genet. 2022 Dec;102(6):517-523
pubmed: 35908153
Clin Genet. 2019 Apr;95(4):462-478
pubmed: 30677142
Nat Commun. 2021 Oct 13;12(1):5962
pubmed: 34645823
Eur J Med Genet. 2022 Apr;65(4):104458
pubmed: 35189377
Aust Paediatr J. 1978 Sep;14(3):182-4
pubmed: 728011
Eur J Hum Genet. 2018 Jul;26(7):996-1006
pubmed: 29695756
Hum Mutat. 2009 Apr;30(4):669-76
pubmed: 19235238
Am J Hum Genet. 2007 May;80(5):988-93
pubmed: 17436254
Bioinformatics. 2019 Jun 1;35(11):1978-1980
pubmed: 30376034
Nucleic Acids Res. 2018 Jan 4;46(D1):D1062-D1067
pubmed: 29165669

Auteurs

Bernt Popp (B)

Institute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.
Center of Functional Genomics, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.

Thierry Bienvenu (T)

INSERM U1266, Institut de Psychiatrie et de Neurosciences de Paris, Université de Paris, Paris, France.

Irina Giurgea (I)

Département de Génétique Médicale, INSERM Childhood Genetic Diseases, AP-HP. Sorbonne Université, Hôpital Trousseau, Paris, France.

Julia Metreau (J)

APHP, Service de Neurologie Pédiatrique, Hôpital Universitaire Bicetre, Le Kremlin-Bicetre, France.

Cornelia Kraus (C)

Institute of Human Genetics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.

André Reis (A)

Institute of Human Genetics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.

Jan Fischer (J)

Institute for Clinical Genetics, University Hospital Carl Gustav Carus at the Technische Universität Dresden, Dresden, Germany.

María Palomares Bralo (MP)

INGEMM, Institute of Medical and Molecular Genetics, Hospital Universitario La Paz, IDIPAZ, Madrid, Spain.
ITHACA European Reference Network, Spain.
CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII, Madrid, Spain.

Jair Tenorio-Castaño (J)

INGEMM, Institute of Medical and Molecular Genetics, Hospital Universitario La Paz, IDIPAZ, Madrid, Spain.
ITHACA European Reference Network, Spain.
CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII, Madrid, Spain.

Pablo Lapunzina (P)

INGEMM, Institute of Medical and Molecular Genetics, Hospital Universitario La Paz, IDIPAZ, Madrid, Spain.
ITHACA European Reference Network, Spain.
CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII, Madrid, Spain.

Berta Almoguera (B)

CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII, Madrid, Spain.
Department of Genetics and Genomics, Fundación Jiménez Díaz University Hospital, Madrid, Spain.

Fermina Lopez-Grondona (F)

CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, ISCIII, Madrid, Spain.
Department of Genetics and Genomics, Fundación Jiménez Díaz University Hospital, Madrid, Spain.

Heinrich Sticht (H)

Institute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.

Christiane Zweier (C)

Institute of Human Genetics, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Department of Human Genetics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH